期刊文献+

降钙素治疗老年性骨质疏松症的临床疗效 被引量:1

Clinical Effects of calcitonin on treatment of the old osteoporosis
暂未订购
导出
摘要 目的 探讨降钙素治疗老年性骨质疏松症的临床疗效。方法  1 6 0例老年性骨质疏松症患者 ,分为实验组和对照组。实验组使用鲑鱼降钙素 (密盖息 )和钙尔奇 -D 和维生素AD ,对照组使用钙尔奇 -D和维生素AD。检测治疗 6个月前后腰椎 3、4 (L3 ,4) ,股骨颈部 ,Wards区 ,桡骨远端的骨密度 (BMD)变化。观察用药 1 0次后骨痛程度的改变。结果 降钙素组治疗 6个月后 ,腰椎 3、4 ,股骨颈 ,Wards区 ,桡骨远端的骨密度较治疗前分别升高 6 5 %、8 1 %、4 6 %、5 8%和 1 1 7% (P <0 0 5 )。对照组无明显改变 (P >0 0 5 )。用药 1 0次后实验组骨痛总有效率为 94 45 % ,对照组为 32 85 % (P <0 0 1 )。结论 降钙素能有效提高骨密度 ,明显缓解疼痛 ,是一种治疗老年性骨质疏松症的良好药物。 Objective To discuss the effects of calcitonin on treatment of the old osteoporosis. Methods 160 cases of the old osteoporosis were divided into experimental group and controlled group. The experimental group was treated with calcitonin and caltrate-D and vitamine AD, the controlled group was treated with caltrate-D and vitamine AD. The BMD of lumbar 3、4, neck of femur, region of Wards, and distal radius were examined at pre-treatment and 6 months post-treatment. The alteration of degree of the bone pain were observed after treatment 10 times. Results The BMD of lumbar 3、4, neck of femur, region of Wards, and distal radius increased significantly 6 5%、8 1%、4 6%、5 8% and 11 7% ( P <0 05). The controlled group were no significant alteration. The total effective rate of experimental group was 94 45%, and the controlled group was 32 85% ( P <0 01). Conclusion Calcitonin could improve effectively the BMD, and relieve the bone pain of osteoporosis. It is a good medicine to treat the old osteoporosis.
作者 董远芳
出处 《现代医院》 2004年第5期18-19,共2页 Modern Hospitals
关键词 降钙素 老年性骨质疏松症 骨密度 骨代谢 Osteoporosis, Calcitonin
  • 相关文献

参考文献5

  • 1[1]Mochizuki K,Inone T,et al.Effect of salmon calcitonin on txptrimental osteoporosis induced by ovariectomy and low-calcium diet in the rat.J Bone Miner Metab,2000,18(4):194-207.
  • 2朱建民,方浩,陈新刚,曾明,金蔚芳,王洪复.降钙素对体外培养成骨细胞的影响[J].中国骨质疏松杂志,2001,7(2):147-148. 被引量:24
  • 3[3]Lane JM,Russell L,Khan SN,et al.Osteoporosis.Clin orthop.2000,372:139-150.
  • 4[4]Siwerman SL,Azria N,et al.The analgesic role of calcitonin following osteoporotic fracture.Osteoporos Iht,2002,13 ( 11 ):858-867.
  • 5程飚,陈峥嵘.密盖息治疗痛性骨质疏松的疗效及耐受性[J].中国临床医学,2000,7(3):312-313. 被引量:7

二级参考文献7

  • 1王洪复,金慰芳,高建军.骨质疏松症防治药物的体外细胞药效评价[J].中国骨质疏松杂志,1999,5(2):58-62. 被引量:41
  • 2Siminoske K, Josse RG. Prevention and management of osteooporosis: consensus statments from the scientific advisory board of the Osteoporosis Society of Canada. 9. Calcifonin in the treatment of osteoporosis. CMAJ, 1996, 155(7): 962~965.
  • 3Plosker GL, Mctavish D. Intranasal alicatonin. A review of its pharmaacological properties and role in the management of postmenopausal osteoporosis. Drugs Aging, 1996, 8(5): 379.
  • 4Abbott TA, Lawrence BJ. Osteoporosis the need for comprehensive treatmet guidelines, Clin Ther, 1996, 18(1): 149~ 159.
  • 5Horst sikorska W, Ruszkowska J, Kosowicz J et al. Comparison of calcitonin tolerance after intramuscular or in tranasal administration in treatment for postmenopausal osteoporosis Przegl Lek, 1996, 53(1): 9~10.
  • 6Ceserani R, Buckley R, Wester W, et al. Calcitonin and prostaglandin system. Life Sci, 1979, 25, 1851~1852.
  • 7Gonnelli S, Cepollaro C. Treatment of post - menoparsal osteoporosis with recombinant human hormone and salmon calcitonin: a placebo controlled study. Clin Endocrinol (Oxf), 1997, 46(1): 55~64.

共引文献28

同被引文献11

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部